Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Mesoblast EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Mesoblast
Mesoblast has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?